세계의 인공와우 시장 : 컴포넌트 유형별, 임플란트 유형별, 환자 유형별, 최종사용자별, 지역별 - 예측(-2030년)

Cochlear Implants Market by Component Type (Cochlear Implants, Upgrades & Accessories), Type of Implants (Unilateral, Bilateral), Patient Type (Adults, Pediatrics), End User (Hospitals, ENT Clinics) - Global Forecast to 2030

US $ 4,950 ￦ 6,896,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,265,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,355,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,933,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 인공와우 시장 규모는 2024년 28억 달러에 달했습니다.

예측 기간 동안 CAGR은 9.2%로 예상되며 2030년에는 47 억 3,000만 달러에 달할 것으로 예상됩니다. 세계 인구의 고령화에 따라 노화에 따른 난청(노인성 난청)이 보편화되면서 인공와우의 잠재적 후보자가 증가하고 있으며, WHO가 보고한 자료에 따르면 전 세계 인구의 20%에 해당하는 15억 명 이상의 난청 환자가 존재하며, 그 중 약 4억 3,000만 명이 장애를 동반한 난청을 앓고 있다고 합니다. 2050년에는 2배 이상 증가한 7억 5,000만 명으로 증가할 것으로 예상됩니다. 이러한 주요 요인인 난청 발생률 증가는 인공와우에 대한 수요를 더욱 촉진하고 있습니다.

조사 범위
조사 대상 연도	2022-2030년
기준 연도	2023년
예측 기간	2024-2030년
검토 단위	금액(USD)
부문	컴포넌트 유형별, 임플란트 유형별, 환자 유형별, 최종사용자별, 지역별
대상 지역	북미,유럽,아시아태평양,중동/아프리카,라틴아메리카,GCC 국가,기타 국가

2023년 인공와우 시장에서 환자 유형별로는 소아과 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.

성인과 소아는 인공와우 시장의 환자 유형별 부문을 구성하고 있으며, 2023년에는 소아과가 인공와우 시장 점유율이 가장 높을 것으로 예상됩니다. 이는 주로 소아 난청 발생률 증가, 기술 발전, 신생아 검진 프로그램을 통한 청각 장애 조기 진단, 조기 개입의 이점에 대한 보호자의 인식 증가에 기인합니다.

최종 사용자별로 인공와우 시장은 병원, 이비인후과 클리닉, 기타로 구분됩니다. 병원이 인공와우를 채택하는 원동력은 환자의 예후 개선, 다학제적 팀 접근, 새로운 수술 기술 등입니다. 또한 병원 인프라에 대한 투자, 특히 신흥 시장에서의 인공와우 보험 적용으로 인해 인공와우에 대한 접근성이 개선되고, 그 결과 인공와우 구매가 용이해져 병원 환경에서 수요가 증가하고 있습니다.

세계 인공와우 시장은 북미, 유럽, 아시아태평양, 중동 및 아프리카, 라틴아메리카, 북미, 유럽, 아시아태평양, 중동 및 아프리카, 라틴아메리카, GCC 국가 등 6개 지역으로 분류됩니다. 예측 기간 동안 아시아태평양은 인공와우 시장이 가장 빠르게 성장할 것으로 예상됩니다. 아시아태평양의 인공와우 수요는 주로 노인 인구 증가, 아시아 국가의 GDP 증가, 아시아태평양 국가의 의료비 지출 증가, 사회적 인식 향상에 기인합니다.

세계의 인공와우 시장에 대해 조사했으며, 부품 유형별/임플란트 유형별/환자 유형별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 분석
• 무역 분석
• 특허 분석
• 2025-2026년 주요 컨퍼런스 및 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 기술 분석
• 투자와 자금조달 시나리오
• AI/생성형 AI가 인공와우 시장에 미치는 영향

제6장 인공와우 시장(컴포넌트 유형별)

• 서론
• 인공와우 시스템
• 업그레이드 및 액세서리

제7장 인공와우 시장(임플란트 유형별)

• 서론
• 한쪽 임플란트
• 양쪽 임플란트

제8장 인공와우 시장(환자 유형별)

• 서론
• 성인
• 소아

제9장 인공와우 시장(최종사용자별)

• 서론
• 병원
• 이비인후과 클리닉
• 기타

제10장 인공와우 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 헬스케어 시스템 현대화와 정부 의식 향상에 초점을 맞혀 시장을 촉진
  • 중동 및 아프리카의 거시경제 전망
• GCC 국가
  • 시장 성장을 지지하는 인프라 개발과 헬스케어 액세스에 중점을 둔다
  • GCC 국가의 거시경제 전망

제11장 경쟁 구도

• 서론
• 주요 시장 진출기업의 전략/강점
• 매출 분석, 2021년-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 시장 진출기업
  • COCHLEAR LTD.
  • SONOVA
  • MED-EL MEDICAL ELECTRONICS
  • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
  • NEUBIO AG
  • TODOC CO., LTD.
  • SHANGHAI LISTENT MEDICAL TECH CO., LTD.

제13장 부록

LSH

영문 목차

영문목차

The global cochlear implants market is valued at an estimated 2.80 billion in 2024 and is projected to reach USD 4.73 billion by 2030, at a CAGR of 9.2% during the forecast period. With the global increase in aging populations, age-related hearing loss (presbycusis) is becoming more common, creating a larger pool of potential candidates for cochlear implantation. WHO-reported data suggests that over 1.5 billion people-just under 20% of the global population-with hearing loss existed, of which around 430 million have disabling hearing loss, and are expected to rise by more than double-750 million in 2050. The main driver of these growth factors, the rising incidence of hearing problems, fuels further demand for CI.

Scope of the Report
Years Considered for the Study	2022-2030
Base Year	2023
Forecast Period	2024-2030
Units Considered	Value (USD)
Segments	Component Type, Type of Implants, Patient Type, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries

In 2023, the pediatric segment accounted for the largest share of the cochlear implants market, by patient type.

Adults and pediatrics make up the patient type-based segments of the cochlear implants market. Market share for cochlear implants was highest in the peadiatrics in 2023. This is mainly due to the high incidence of hearing loss in children, increasing technological advancements, early diagnosis of hearing impairments through newborn screening programs, and growing awareness among parents about the benefits of early intervention.

"The hospitals segment is projected to witness the highest growth rate in the cochlear implants market, by end user, during the forecast period."

Based on end user, the cochlear implants market is segmented into hospitals, ENT clinics, and other end users. The driving factors that force hospitals to adopt cochlear implants include better patient outcomes, a multidisciplinary team approach, and novel surgical technologies. Besides, investment in hospital infrastructure-especially within emerging markets-and insurance cover for cochlear implants ensure better access and, consequently, better affordability of cochlear implants, increasing their demand in the hospital environment.

"The Asia Pacific region is projected to witness highest growth rate in the cochlear implants market during the forecast period"

The global cochlear implants market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the cochlear implants market is expected to grow at the fastest rate in the Asia Pacific region. The demand for cochlear implants in the APAC is mainly driven by the growing geriatric population, the increasing GDP of Asian countries, the rising healthcare expenditure in the APAC countries, and growing public awareness.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 35%, Europe - 31%, Asia Pacific - 22%, Latin America - 9%, Middle East & Africa - 2%, and the GCC Countries - 1%

Lists of Companies Profiled in the Report:

Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China).

Research Coverage:

In this report, the cochlear implants market has been categorized based on type of implants (unilateral implants, bilateral implants), end user (hospitals, ENT clinics, and other end users), patient type (adults, pediatrics), component type (cochlear implant systems, upgrades & accessories), and region (Europe, Middle East & Africa, North America, Latin America, Asia Pacific, and the GCC Countries).

Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the cochlear implants market's expansion is included in detail in this study. An exhaustive study of the key players in the cochlear implants market has been done to provide insights into their business profile, products offered, noteworthy strategies, product launches and approvals, and other recent activities pertaining to the market.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall cochlear implants market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.

The report provides insights on the following pointers:

• Analysis of key drivers: (Rising prevalence of hearing impairment, growing geriatric population, and comprehensive insurance coverage and favorable reimbursement policies), restraints (High cost of cochlear implants and associated surgeries and surgical risks, procedural complications, and long post-surgery rehabilitation), opportunities (Lucrative growth opportunities in emerging economies, technological innovations in cochlear implants, and integration with digital health platforms), and challenges (Shortage of skilled professionals performing ENT procedures, competition from alternative solutions) influencing the growth of the in cochlear implants market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the cochlear implants market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cochlear implants market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Cochlear Ltd. (Australia), Sonova (Switzerland), and MED-EL Medical Electronics (Austria) are among others, in the cochlear implants market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key industry insights
    • 2.1.2.5 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.1.1 Presentations of companies and primary interviews
      • 2.2.1.1.2 Primary interviews
      • 2.2.1.1.3 Country-based approach for estimating global market size
      • 2.2.1.1.4 Approach for estimating global market size based on units sold
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
  • 2.5.1 MARKET ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 COCHLEAR IMPLANTS MARKET OVERVIEW
• 4.2 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE AND COUNTRY (2023)
• 4.3 COCHLEAR IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 COCHLEAR IMPLANTS MARKET: REGIONAL MIX (2024-2030)
• 4.5 COCHLEAR IMPLANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of hearing impairment
    • 5.2.1.2 Growing geriatric population
    • 5.2.1.3 Comprehensive insurance coverage and favorable reimbursement policies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of cochlear implants and associated surgeries
    • 5.2.2.2 Surgical risks, procedural complications, and long post-surgery rehabilitation
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Lucrative growth opportunities in emerging economies
    • 5.2.3.2 Technological innovations in cochlear implants
    • 5.2.3.3 Integration with digital health platforms
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled professionals performing ENT procedures
    • 5.2.4.2 Competition from alternative solutions
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021-2023
  • 5.3.2 AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021-2023
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • 5.6.1 ROLE IN ECOSYSTEM
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 REGULATORY ANALYSIS
  • 5.9.1 REGULATORY FRAMEWORK
    • 5.9.1.1 North America
      • 5.9.1.1.1 US
      • 5.9.1.1.2 Canada
    • 5.9.1.2 Europe
    • 5.9.1.3 Asia Pacific
      • 5.9.1.3.1 Japan
      • 5.9.1.3.2 China
      • 5.9.1.3.3 India
    • 5.9.1.4 Latin America
      • 5.9.1.4.1 Brazil
      • 5.9.1.4.2 Mexico
    • 5.9.1.5 Middle East
    • 5.9.1.6 Africa
  • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 902140
  • 5.10.2 EXPORT DATA FOR HS CODE 902140
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF MAJOR PATENTS
• 5.12 KEY CONFERENCES & EVENTS, 2025-2026
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 Electrode-based auditory nerve stimulation
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 Bimodal hearing solutions
  • 5.14.3 ADJACENT TECHNOLOGIES
    • 5.14.3.1 Bone conduction hearing devices
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET

6 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE

• 6.1 INTRODUCTION
• 6.2 COCHLEAR IMPLANT SYSTEMS
  • 6.2.1 INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH
• 6.3 UPGRADES & ACCESSORIES
  • 6.3.1 FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH

7 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT

• 7.1 INTRODUCTION
• 7.2 UNILATERAL IMPLANTS
  • 7.2.1 BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS
• 7.3 BILATERAL IMPLANTS
  • 7.3.1 IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH

8 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE

• 8.1 INTRODUCTION
• 8.2 ADULTS
  • 8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS
• 8.3 PEDIATRICS
  • 8.3.1 EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH

9 COCHLEAR IMPLANTS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH
• 9.3 ENT CLINICS
  • 9.3.1 INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH
• 9.4 OTHER END USERS

10 COCHLEAR IMPLANTS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American cochlear implants market during study period
  • 10.2.3 CANADA
    • 10.2.3.1 Growing geriatric population and rising government health expenditure to propel market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 High incidence of hearing impairment and favorable government health insurance schemes to augment growth
  • 10.3.3 UK
    • 10.3.3.1 Increased prevalence of hearing problems among older adults to boost market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Need for advanced treatment options and high government healthcare expenditure to spur market adoption
  • 10.3.5 ITALY
    • 10.3.5.1 Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants
  • 10.3.6 SPAIN
    • 10.3.6.1 Long waiting times for ENT appointments and lack of reimbursement to limit market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Advanced healthcare system and rapidly growing geriatric population to support market growth
  • 10.4.3 CHINA
    • 10.4.3.1 Modernization of healthcare facilities and increased patient pool to drive market
  • 10.4.4 INDIA
    • 10.4.4.1 Higher incidence of hearing impairment and increased government funds to propel market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increasing number of ENT specialists and rising government funding in public hospitals to support market growth
  • 10.4.6 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Favorable investment scenario from medical device manufacturers to favor market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increased FDI and growing presence of key healthcare companies to support market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 10.7 GCC COUNTRIES
  • 10.7.1 EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH
  • 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET
• 11.3 REVENUE ANALYSIS, 2021-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Component type footprint
    • 11.5.5.4 Patient type footprint
    • 11.5.5.5 End-user footprint
• 11.6 COMPANY VALUATION & FINANCIAL METRICS
• 11.7 BRAND/PRODUCT COMPARISON
• 11.8 COMPETITIVE SCENARIO
  • 11.8.1 PRODUCT LAUNCHES & APPROVALS
  • 11.8.2 DEALS
  • 11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 COCHLEAR LTD.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 SONOVA
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Other developments
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 MED-EL MEDICAL ELECTRONICS
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Other developments
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
  • 12.1.5 NEUBIO AG
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
  • 12.1.6 TODOC CO., LTD.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 SHANGHAI LISTENT MEDICAL TECH CO., LTD.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료